Professional
Added to YB: 2026-07-15
Pitch date: 2026-07-12
LNSR [bullish]
LENSAR, Inc.
-3.52%
current return
Author Info
Company Info
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally.
Market Cap
$70.4M
Pitch Price
$5.97
Price Target
N/A
Dividend
N/A
EV/EBITDA
-3.69
P/E
2.55
EV/Sales
1.27
Sector
Health Care Equipment and Supplies
Category
turnaround
Cedar Grove Capital Management New Portfolio Holding: LENSAR, Inc.
LNSR (re-established position): Re-established position in LENSAR after exiting when Alcon (ALC) merger was terminated. With merger-arb overhang cleared, market now values co on standalone fundamentals. Thesis: LENSAR can rebuild operating momentum & valuation obscured during extended deal process.
Read full article (1 min)